Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)
Completed
National Institute of Mental Health (NIMH)
Phase 2/Phase 3
2001-01-01
The purpose of the study is to determine how best to treat adolescents with depression that
is "resistant" to the first SSRI antidepressant they have tried. Participants receive one of
three other antidepressant medications, either alone or in combination with cognitive
behavioral therapy.
Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)
Completed
University of Pittsburgh
Phase 2/Phase 3
2001-01-01
The purpose of the study is to determine how best to treat adolescents with depression that
is "resistant" to the first SSRI antidepressant they have tried. Participants receive one of
three other antidepressant medications, either alone or in combination with cognitive
behavioral therapy.
Magnetic Stimulation Therapy for Treating Vascular Depression
Completed
National Institute of Mental Health (NIMH)
Phase 3
2001-09-01
This 12-week study will evaluate the effectiveness of repetitive transcranial magnetic
stimulation (rTMS) of the brain, followed by citalopram (Celexa®), for treatment of
depression associated with small vascular lesions in the brain (vascular depression).
Magnetic Stimulation Therapy for Treating Vascular Depression
Completed
University of Iowa
Phase 3
2001-09-01
This 12-week study will evaluate the effectiveness of repetitive transcranial magnetic
stimulation (rTMS) of the brain, followed by citalopram (Celexa®), for treatment of
depression associated with small vascular lesions in the brain (vascular depression).
Antidepressant Treatment in Older Adults With Schizophrenia
Completed
National Institute of Mental Health (NIMH)
N/A
2001-09-01
The purpose of this study is to evaluate the safety and effectiveness of citalopram (Celexa)
for the treatment of depressive symptoms in middle-aged and elderly patients with
schizophrenia.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
